557 related articles for article (PubMed ID: 20020257)
1. Drug-induced liver injury.
Holt M; Ju C
Handb Exp Pharmacol; 2010; (196):3-27. PubMed ID: 20020257
[TBL] [Abstract][Full Text] [Related]
2. Idiosyncratic drug-induced liver injury: an update on the 2007 overview.
Hussaini SH; Farrington EA
Expert Opin Drug Saf; 2014 Jan; 13(1):67-81. PubMed ID: 24073714
[TBL] [Abstract][Full Text] [Related]
3. Review article: drug-induced liver injury in clinical practice.
Björnsson E
Aliment Pharmacol Ther; 2010 Jul; 32(1):3-13. PubMed ID: 20374223
[TBL] [Abstract][Full Text] [Related]
4. Signal transduction pathways involved in drug-induced liver injury.
Han D; Shinohara M; Ybanez MD; Saberi B; Kaplowitz N
Handb Exp Pharmacol; 2010; (196):267-310. PubMed ID: 20020266
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based selection of training compounds for use in the mechanism-based integrated prediction of drug-induced liver injury in man.
Dragovic S; Vermeulen NP; Gerets HH; Hewitt PG; Ingelman-Sundberg M; Park BK; Juhila S; Snoeys J; Weaver RJ
Arch Toxicol; 2016 Dec; 90(12):2979-3003. PubMed ID: 27659300
[TBL] [Abstract][Full Text] [Related]
6. Utilization of causal reasoning of hepatic gene expression in rats to identify molecular pathways of idiosyncratic drug-induced liver injury.
Laifenfeld D; Qiu L; Swiss R; Park J; Macoritto M; Will Y; Younis HS; Lawton M
Toxicol Sci; 2014 Jan; 137(1):234-48. PubMed ID: 24136188
[TBL] [Abstract][Full Text] [Related]
7. Role of immune reactions in drug-induced liver injury (DILI).
Ju C; Reilly T
Drug Metab Rev; 2012 Feb; 44(1):107-15. PubMed ID: 22235834
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management.
Mosedale M; Watkins PB
Clin Pharmacol Ther; 2017 Apr; 101(4):469-480. PubMed ID: 27861792
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced liver injury: insights from genetic studies.
Andrade RJ; Robles M; Ulzurrun E; Lucena MI
Pharmacogenomics; 2009 Sep; 10(9):1467-87. PubMed ID: 19761370
[TBL] [Abstract][Full Text] [Related]
10. Drug-Induced liver injury with hypersensitivity features has a better outcome: a single-center experience of 39 children and adolescents.
Devarbhavi H; Karanth D; Prasanna KS; Adarsh CK; Patil M
Hepatology; 2011 Oct; 54(4):1344-50. PubMed ID: 21735470
[TBL] [Abstract][Full Text] [Related]
11. Antituberculous drug-induced liver injury: current perspective.
Devarbhavi H
Trop Gastroenterol; 2011; 32(3):167-74. PubMed ID: 22332331
[TBL] [Abstract][Full Text] [Related]
12. The Liver Toxicity Knowledge Base (LKTB) and drug-induced liver injury (DILI) classification for assessment of human liver injury.
Thakkar S; Chen M; Fang H; Liu Z; Roberts R; Tong W
Expert Rev Gastroenterol Hepatol; 2018 Jan; 12(1):31-38. PubMed ID: 28931315
[TBL] [Abstract][Full Text] [Related]
13. Predicting and preventing acute drug-induced liver injury: what's new in 2010?
Liss G; Rattan S; Lewis JH
Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1047-61. PubMed ID: 20615079
[TBL] [Abstract][Full Text] [Related]
14. Metabolic activation and drug-induced liver injury: in vitro approaches for the safety risk assessment of new drugs.
Gómez-Lechón MJ; Tolosa L; Donato MT
J Appl Toxicol; 2016 Jun; 36(6):752-68. PubMed ID: 26691983
[TBL] [Abstract][Full Text] [Related]
15. Adverse drug reactions and organ damage: The liver.
Licata A
Eur J Intern Med; 2016 Mar; 28():9-16. PubMed ID: 26827101
[TBL] [Abstract][Full Text] [Related]
16. Assessment of reactive metabolites in drug-induced liver injury.
Lee KS; Oh SJ; Kim HM; Lee KH; Kim SK
Arch Pharm Res; 2011 Nov; 34(11):1879-86. PubMed ID: 22139687
[TBL] [Abstract][Full Text] [Related]
17. Approaches to the study of drug-induced liver injury.
Fontana RJ
Clin Pharmacol Ther; 2010 Sep; 88(3):416-9. PubMed ID: 20664536
[TBL] [Abstract][Full Text] [Related]
18. An update on drug induced liver injury.
Rangnekar AS; Fontana RJ
Minerva Gastroenterol Dietol; 2011 Jun; 57(2):213-29. PubMed ID: 21587150
[TBL] [Abstract][Full Text] [Related]
19. Immunological mechanisms of drug-induced liver injury.
Ju C
Curr Opin Drug Discov Devel; 2005 Jan; 8(1):38-43. PubMed ID: 15679170
[TBL] [Abstract][Full Text] [Related]
20. FDA-approved drug labeling for the study of drug-induced liver injury.
Chen M; Vijay V; Shi Q; Liu Z; Fang H; Tong W
Drug Discov Today; 2011 Aug; 16(15-16):697-703. PubMed ID: 21624500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
